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Background: Mitochondrial DNA 5178 cytosine/adenosine (Mt5178 C/A) polymorphism is associated with longevity
in the Japanese. The purpose of this study is to investigate whether Mt5178 C/A polymorphism modifies the effects
of habitual smoking or habitual drinking on serum non-high-density lipoprotein (non-HDL) cholesterol levels in
middle-aged Japanese men.
Methods: A total of 394 male subjects (age 53.9 ± 7.9 years; mean ± SD) were selected from among individuals visiting
the hospital for regular medical check-ups. After Mt5178 C/A genotyping, a cross-sectional study assessing the joint
effects of Mt5178 C/A polymorphism and cigarette smoking or alcohol drinking on serum non-HDL cholesterol levels
was conducted. High levels of serum non-HDL cholesterol were defined as serum non-HDL cholesterol levels ≥160
mg/dl or ≥190 mg/dl.
Results: For men with Mt5178A, cigarette smoking may increase serum non-HDL cholesterol levels (P for
trend < 0.001), as well as the risk of high levels of non-HDL cholesterol (serum non-HDL cholesterol levels ≥160 mg/dl,
P for trend < 0.001; serum non-HDL cholesterol levels ≥190 mg/dl, P for trend = 0.004). On the other hand, for men with
Mt5178C, after adjusting for age and body mass index, alcohol consumption may decrease serum non-HDL cholesterol
levels (P for trend = 0.043) and the risk of high levels of non-HDL cholesterol (serum non-HDL cholesterol level ≥160
mg/dl, P for trend = 0.005).
Conclusions: These gene-environment interactions on serum non-HDL cholesterol levels may contribute to the
establishment of individualized prevention of the risk of high levels of serum non-HDL cholesterol.
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Non-high-density lipoprotein (non-HDL) cholesterol,
which includes the cholesterol carried by apolipopro-
tein B-containing particles, has a clear pathophysio-
logic link to the development of atherosclerosis, and
outperforms other lipid measures in predicting both
subclinical atherosclerosis and cardiovascular disease
[1]. Orakzai and colleagues also reported that non-
HDL cholesterol is more strongly associated with sub-
clinical atherosclerosis than all other routine lipid
measures, and proposed that non-HDL cholesterol is a
crucial treatment target in primary prevention of cor-
onary heart disease [2].
It is important for primary prevention to detect modifi-
able factors influencing serum non-HDL cholesterol levels.
Large-scale population-based cross-sectional studies have
indicated that serum non-HDL cholesterol levels are
strongly influenced by cigarette smoking [3] and alcohol
consumption [3,4]. Several gene-environment interactions
on serum non-HDL cholesterol levels have been published
[5-7]. Vogel and colleagues reported the combined effects
of cyclooxygenase-2 (COX-2) polymorphism and alcohol
consumption on serum non-HDL cholesterol levels [5].
Therefore, even in the establishment of primary prevention
for high levels of non-HDL cholesterol, genetic information
deserves consideration.
In population genetics, mitochondrial DNA sequences
are utilized for climatic adaptation research [8,9]. Mito-
chondrial DNA haplogroups A, C, D and X reportedly
experience much greater cold stress than haplogroup B
or L [8]. In physiological anthropology, Nishimura and
colleagues reported that seasonal cold acclimatization in
haplogroup D individuals relies on more efficient metabol-
ism, while that in haplogroup non-D individuals relies
more on insulation [10]. Mitochondrial DNA 5178 cyto-
sine/adenine (Mt5178 C/A) polymorphism is also recog-
nized as NADH dehydrogenase subunit-2 237 leucine/
methionine (ND2-237 Leu/Met) polymorphism. Mt5178A
is a genetic marker of haplogroup D. The frequency of the
Mt5178A genotype is significantly higher in Japanese cen-
tenarians than in the general population and, conse-
quently, Mt5178 C/A polymorphism is associated with
longevity in the Japanese [11]. Although Mt5178C geno-
type is reportedly related to performance in elite endur-
ance runners [12], Japanese individuals with Mt5178C are
more susceptible to lifestyle-related atherosclerotic
diseases, such as myocardial infarction [13,14] and
cerebrovascular disorders [15], than those with Mt5178A.
Moreover, this polymorphism subclinically influences the
effects of habitual smoking and habitual drinking on
serum lipid levels [16], and reportedly modifies their ef-
fects on the risk of dyslipidemia [17,18]. However, to our
knowledge, there have been no reports focusing on the
combined effects of Mt5178 C/A polymorphism andcigarette smoking or alcohol consumption on serum non-
HDL cholesterol levels.
This study aims to investigate whether longevity-
associated Mt5178 C/A polymorphism influences the
effects of habitual drinking or habitual smoking on
serum non-HDL cholesterol levels or the risk of high




Participants were recruited from among individuals visit-
ing the Mito Red Cross Hospital for regular medical
check-ups between August 1999 and August 2000. This
study was conducted in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee
of Kyorin University School of Medicine. Written in-
formed consent was obtained from 602 volunteers before
participation. Because the number of women was insuffi-
cient for classification into groups based on Mt5178 C/A
genotype and smoking status, women were excluded. Pa-
tients taking antihyperlipidemic medication were ex-
cluded, and diabetic patients were also excluded because
of the higher prevalence of dyslipidemia in diabetic pa-
tients when compared with non-diabetic patients [19].
Thus, 406 men were enrolled in the study. Twelve individ-
uals with unclear data were also excluded. Therefore, sub-
jects comprised 394 Japanese men (age 53.9 ± 7.9 years;
mean ± SD).
Clinical characteristics of subjects
Determination of blood chemical and physical data was
conducted as described previously [20]. Serum non-HDL
cholesterol levels were calculated by subtracting serum
HDL cholesterol levels from serum total cholesterol
levels. According to the National Cholesterol Education
Program Adult Treatment Panel III (ATP III) [21], serum
low-density lipoprotein (LDL) cholesterol <100 mg/dl
is optimal, 100 to 129 mg/dl is near optimal, 130 to
159 mg/dl is borderline high, 160 to 189 mg/dl is high,
and ≥190 mg/dl is very high. ATP III recommends that
the goal for serum non-HDL cholesterol be 30 mg/dl
higher than the serum LDL cholesterol goal [21]. There-
fore, high levels of serum non-HDL cholesterol were
preventively or clinically defined as serum non-HDL
cholesterol levels ≥160 mg/dl or ≥190 mg/dl. Body mass
index (BMI) was defined as the ratio of subject weight
(kg) to the square of subject height (m). A survey of
cigarette smoking, alcohol consumption and coffee con-
sumption was performed by means of questionnaire.
Smoking status was classified based on the number of
cigarettes smoked per day (never- or ex-smokers; 1 to 20
cigarettes smoked per day; and >20 cigarettes smoked
per day). Alcohol consumption was classified based on
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which include those who drink several times per week or
per month; and non- or ex-drinkers). Coffee consump-
tion was classified based on number of cups of coffee
per day (≤1 cup per day; 2 to 3 cups per day; and ≥4
cups per day). For use of antihypertensive medication,
subjects were classified as taking no drug treatment or
taking medicine.
Genotyping
DNA was extracted from white blood cells using the
DNA Extractor WB kit (Wako Pure Chemical Industries,
Osaka, Japan). Mt5178 C/A polymorphism was detected
by polymerase chain reaction (PCR) and digestion with
AluI restriction enzyme. The sequence of primers was:
forward 5′-CTTAGCATACTCCTCAATTACCC-3′, re-
verse 5′-GTGAATTCTTCGATAATGGCCCA-3′. PCR
was performed with 50 ng genomic DNA in buffer con-
taining 0.2 μmol/l each primer, 1.25 mmol/l dNTPs, 1.5
mmol/l MgCl2, and 1 U Taq DNA polymerase (Takara
Bio Inc., Shiga, Japan). After an initial denaturation at
94°C for 5 minutes, PCR was conducted through 40 cy-
cles as follows: denaturation at 94°C for 30 seconds, an-
nealing at 60°C for 60 seconds and polymerase extension
at 72°C for 90 seconds. After cycling, a final extension at
72°C for 10 minutes was performed. PCR products were
digested with the AluI restriction enzyme (Nippon Gene,
Tokyo, Japan) at 37°C overnight, followed by electro-




Body mass index (kg/m2) 2
Serum total cholesterol (mg/dl) 2
Serum HDL cholesterol (mg/dl) 5
Serum non-HDL cholesterol (mg/dl) 1
Serum LDL cholesterol (mg/dl) 1
Serum triglyceride (mg/dl) 1
Systolic blood pressure (mmHg) 1
Diastolic blood pressure (mmHg) 7
Fasting plasma glucose (mg/dl) 9
Smoking status (never- or ex-/1-20 cigarettes
per day/>20 cigarettes per day) (%)
5
Alcohol consumption (daily/occasionally/non- or ex-) (%) 4
Coffee consumption (≤1 cup per day/2-3 cups
per day/≥4 cups per day) (%)
6
Antihypertensive (%) 1
Age, body mass index, serum total cholesterol levels, serum HDL cholesterol levels, ser
levels, systolic blood pressure, diastolic blood pressure and fasting plasma glucose leve
consumption and antihypertensive use, P values were calculated by chi-squared test. A
cytosine (Mt5178C) and mitochondrial DNA 5178 adenosine (Mt5178A). HDL, high-denbromide for visualization under ultraviolet light. The ab-
sence of an AluI site was designated as Mt5178A, and
the presence of this restriction site was designated as
Mt5178C.
Statistical analyses
Statistical analyses were performed using SAS statis-
tical software, version 9.2 for Windows (SAS Institute,
Inc., Cary, North Carolina). Multiple logistic regres-
sion analysis was used to calculate odds ratios (ORs)
for high levels of serum non-HDL cholesterol. For
multiple logistic regression analysis and analysis of
covariance, habitual alcohol consumption (non- or ex-
drinkers = 0, occasional drinkers = 1, daily drinkers = 2),
coffee consumption (≤1 cup per day = 1, 2 to 3 cups per
day = 2, ≥4 cups per day = 3) and antihypertensive medi-
cation use (no use of antihypertensive = 0, use of antihy-
pertensive = 1) were numerically coded. Differences with
P values of less than 0.05 were considered to be statisti-
cally significant.
Results
No significant differences in biophysical or biochemical
characteristics were observed between the Mt5178C and
Mt5178A genotypes (Table 1). No significant differences
in serum non-HDL cholesterol levels were observed be-
tween the Mt5178 C/A genotypes. No significant differ-
ences in smoking status or alcohol consumption status
were observed between the Mt5178 C/A genotypes./A genotype
t5178C Mt5178A P value
= 239 N = 155
4.3 ± 7.8 53.2 ± 7.8 0.171
3.3 ± 2.8 23.5 ± 2.6 0.461
03.5 ± 34.3 202.1 ± 31.8 0.672
4.6 ± 13.6 56.3 ± 16.2 0.269
48.9 ± 36.3 145.8 ± 34.6 0.395
21.6 ± 34.8 117.9 ± 30.5 0.281
36.7 ± 91.1 139.5 ± 90.8 0.766
25.8 ± 15.9 125.7 ± 14.1 0.940
4.0 ± 10.7 73.8 ± 9.1 0.823





um non-HDL cholesterol levels, serum LDL cholesterol levels, serum triglyceride
ls are given as means ± SD. For smoking status, alcohol consumption, coffee
ll P values depict significance of differences between mitochondrial DNA 5178
sity lipoprotein; LDL, low-density lipoprotein.
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smoked per day was positively and significantly asso-
ciated with serum non-HDL cholesterol levels (P for
trend < 0.001) (Table 2). After adjustment for age and
BMI, or for age, BMI, alcohol consumption, coffee
consumption and use of antihypertensive medication,
the number of cigarettes smoked per day was also posi-
tively and significantly associated with serum non-HDL
cholesterol levels (adjusted P for trend < 0.001, and
adjusted P for trend < 0.001, respectively). Serum non-
HDL cholesterol levels were significantly higher in those
who smoked >20 cigarettes per day than in never- or ex-
smokers (P < 0.001). After adjustment for age and BMI, or
for age, BMI, alcohol consumption, coffee consumption
and use of antihypertensive medication, serum non-HDL
cholesterol levels were significantly higher in those who
smoked >20 cigarettes per day than in never- or ex-
smokers (P = 0.001 and P = 0.002, respectively). Serum
non-HDL cholesterol levels were significantly higher
in those who consumed >20 cigarettes per day than in
those who consumed 1 to 20 cigarettes per day (P = 0.023).
After adjustment, a significant difference was not observed.
However, for Mt5178C genotypic men, no significant asso-
ciations between cigarette smoking and serum non-HDL
cholesterol levels were observed.
In the case of high levels of serum non-HDL cholesterol
defined as serum non-HDL cholesterol levels ≥160 mg/dl,
for subjects with Mt5178A the risk of high levels of serum
non-HDL cholesterol may depend on daily number of cig-
arettes smoked (P for trend < 0.001) (Table 3). After ad-
justment, the positive association between increasing daily
number of cigarettes smoked and the risk of high levels of
serum non-HDL cholesterol remained significant. The
crude OR for high levels of serum non-HDL cholesterol
was significantly higher in subjects who smoked 1 to 20






Mt5178C N = 142 N =
non-HDL cholesterol 149.2 ± 3.0 144.7
non-HDL cholesterol† 148.8 ± 3.0 145.4
non-HDL cholesterol‡ 151.8 ± 4.6 146.8
Mt5178A N = 92 N =
non-HDL cholesterol 139.9 ± 3.5 145.8
non-HDL cholesterol† 139.0 ± 3.4 149.4
non-HDL cholesterol‡ 141.2 ± 5.4 150.1
†non-HDL cholesterol levels are given as least-square mean ± SE adjusted for age an
mean ± SE adjusted for age, body mass index, alcohol consumption, coffee consum
comparisons was applied. *P < 0.005 vs never- or ex-smokers, **P < 0.001 vs never-
per day. HDL, high-density lipoprotein; Mt5178C, mitochondrial DNA 5178 cytosine;per day than in never- or ex-smokers (OR = 2.254, 95%
confidence interval (CI) = 1.015 to 5.007, P = 0.046, and
OR = 6.339, 95% CI = 2.364 to 17.00, P < 0.001, respect-
ively). After adjustment for age and BMI, or for age, BMI,
habitual alcohol consumption, coffee consumption and
use of antihypertensive medication, a significant OR
remained. In the case of high levels of serum non-HDL
cholesterol defined as serum non-HDL cholesterol
levels ≥190 mg/dl, the risk of high levels of serum
non-HDL cholesterol may also depend on daily num-
ber of cigarettes smoked (P for trend = 0.004). After
adjustment, the positive association between increasing
daily number of cigarettes smoked and the risk of high
levels of serum non-HDL cholesterol also remained
significant. The crude OR for high levels of serum
non-HDL cholesterol was significantly higher in sub-
jects who consumed >20 cigarettes per day than in
never- or ex-smokers (OR = 6.271, 95% CI = 1.862 to
21.11, P = 0.003). After adjusting for age and BMI, or
for age, BMI, habitual alcohol consumption, coffee
consumption and use of antihypertensive medication, a
significant OR remained. On the other hand, for nei-
ther definition of high levels of serum non-HDL chol-
esterol, the association between Mt5178C genotype
and the risk of high levels of serum non-HDL choles-
terol was dependent on the daily number of cigarettes
smoked.
For Mt5178C genotypic men, alcohol consumption was
negatively associated with serum non-HDL cholesterol
levels (Table 4). After adjustment for age and BMI, or for
age, BMI, cigarette smoking, coffee consumption and use
of antihypertensive medication, alcohol consumption was
negatively and significantly associated with serum non-
HDL cholesterol levels (adjusted P for trend = 0.043 and
adjusted P for trend = 0.040, respectively). After adjust-
ment for age and BMI, serum non-HDL cholesterol levelsng status and Mt5178 C/A genotype





70 N = 27
± 4.3 158.6 ± 7.0 P = 0.557
± 4.3 160.5 ± 7.0 P = 0.333
± 5.2 162.3 ± 7.7 P = 0.500
40 N = 23
± 5.3 169.3 ± 6.9**,§ P < 0.001
± 5.2 166.7 ± 6.7* P < 0.001
± 6.1 168.0 ± 8.1* P < 0.001
d body mass index; ‡non-HDL cholesterol levels are given as least-square
ption and antihypertensive medication use. Bonferroni correction for multiple
or ex-smokers, §P < 0.001 vs current smokers who smoked 1 to 20 cigarettes
Mt5178A, mitochondrial DNA 5178 adenosine.






Frequency OR (95% CI) Adjusted OR†
(95% CI)
Adjusted OR‡











0 (never- or ex-smokers) 95 (66.9) 47 (33.1) 1 (reference) 1 (reference) 1 (reference)
1-20 46 (65.7) 24 (34.3) 1.055 (0.576-1.931) 1.079 (0.577-2.016) 0.955 (0.491-1.857)
>20 16 (59.3) 11 (40.7) 1.390 (0.598-3.230) 1.436 (0.591-3.492) 1.498 (0.596-3.765)
P for trend = 0.495 P for trend = 0.403 P for trend = 0.619
Mt5178A
0 (never- or ex-smokers) 71 (77.2) 21 (22.8) 1 (reference) 1 (reference) 1 (reference)
1-20 24 (60.0) 16 (40.0) 2.254 (1.015-5.007)* 3.035 (1.269-7.259)* 2.580 (1.027-6.481)*
>20 8 (34.8) 15 (65.2) 6.339 (2.364-17.00)*** 6.191 (2.258-16.97)*** 5.681 (2.022-15.96)**






0 (never- or ex-smokers) 126 (88.7) 16 (11.3) 1 (reference) 1 (reference) 1 (reference)
1-20 62 (88.6) 8 (11.4) 1.016 (0.413-2.503) 1.071 (0.427-2.686) 0.890 (0.334-2.376)
>20 22 (81.5) 5 (18.5) 1.790 (0.595-5.385) 1.943 (0.6.5-6.244) 2.210 (0.654-7.469)
P for trend = 0.397 P for trend = 0.313 P for trend = 0.368
Mt5178A
0 (never- or ex-smokers) 86 (93.5) 6 (6.5) 1 (reference) 1 (reference) 1 (reference)
1-20 35 (87.5) 2 (12.5) 2.048 (0.587-7.148) 2.420 (0.655-8.944) 2.815 (0.692-11.45)
>20 16 (69.6) 7 (30.4) 6.271 (1.862-21.11)** 6.081 (1.772-20.86)** 6.315 (1.715-23.25)*
P for trend = 0.004 P for trend = 0.006 P for trend = 0.007
†OR adjusted for age and body mass index. ‡OR adjusted for age, body mass index, habitual alcohol consumption, coffee consumption and antihypertensive
medication. *P < 0.05, **P < 0.005, ***P < 0.001. CI, confidence interval; HDL, high-density lipoprotein; Mt5178C, mitochondrial DNA 5178 cytosine; Mt5178A,
mitochondrial DNA 5178 adenosine; OR, odds ratio.
Table 4 Serum non-HDL cholesterol levels classified by drinking status and Mt5178 C/A genotype
Drinking status P for trend
Non- or ex-drinkers Occasional drinkers Daily drinkers
Mt5178C N = 44 N = 84 N = 111
non-HDL cholesterol 159.8 ± 5.4 146.2 ± 3.9 146.7 ± 3.4 P = 0.088
non-HDL cholesterol† 161.8 ± 5.4 145.7 ± 3.9* 146.3 ± 3.4* P = 0.043
non-HDL cholesterol‡ 164.5 ± 6.7 148.0 ± 5.5* 148.4 ± 4.6* P = 0.040
Mt5178A N = 21 N = 60 N = 74
non-HDL cholesterol 151.2 ± 7.6 147.9 ± 4.5 142.6 ± 4.0 P = 0.245
non-HDL cholesterol† 153.7 ± 7.4 147.6 ± 4.3 142.1 ± 3.9 P = 0.140
non-HDL cholesterol‡ 159.7 ± 8.3 152.3 ± 5.7 147.3 ± 5.3 P = 0.114
†non-HDL cholesterol levels are given as least-square mean ± SE adjusted for age and body mass index; ‡non-HDL cholesterol levels are given as least-square
mean ± SE adjusted for age, body mass index, cigarette smoking, coffee consumption and antihypertensive medication use. Bonferroni correction for multiple
comparisons was applied. *P < 0.05 vs non- or ex-drinkers. HDL, high-density lipoprotein; Mt5178C, mitochondrial DNA 5178 cytosine; Mt5178A, mitochondrial
DNA 5178 adenosine.
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drinkers than in non- or ex-drinkers (P = 0.049 and P =
0.047, respectively). Moreover, after adjustment for age
and BMI or for age, BMI, cigarette smoking, coffee con-
sumption and use of antihypertensive medication, serum
non-HDL cholesterol levels were significantly lower in oc-
casional drinkers or in daily drinkers than in non- or ex-
drinkers (P = 0.048 and P = 0.044, respectively). On the
other hand, for Mt5178A genotypic men, no significant
associations between alcohol consumption and serum
non-HDL cholesterol levels were observed.
In the case of high levels of serum non-HDL choles-
terol defined as serum non-HDL cholesterol levels ≥160
mg/dl, for subjects with Mt5178C the risk of high levels
of serum non-HDL cholesterol may depend on alcohol
consumption (P for trend = 0.012) (Table 5). After ad-
justment, the negative association between increasingTable 5 Odds ratios and 95% confidence intervals for high le
















Non- or ex-drinkers 22 (50.0) 22 (50.0)
Occasional drinkers 55 (65.5) 29 (34.5)
Daily drinkers 80 (72.1) 31 (27.9)
Mt5178A
Non- or ex-drinkers 17 (81.0) 4 (19.0)
Occasional drinkers 38 (63.3) 22 (36.7)






Non- or ex-drinkers 36 (81.5) 8 (18.2)
Occasional drinkers 74 (88.1) 10 (11.9)
Daily drinkers 100 (90.1) 11 (9.9)
Mt5178A
Non- or ex-drinkers 19 (90.5) 2 (9.5)
Occasional drinkers 54 (90.0) 6 (10.0)
Daily drinkers 64 (86.5) 10 (13.5)
†OR adjusted for age and body mass index. ‡OR adjusted for age, body mass index, cig
**P < 0.005. CI, confidence interval; HDL, high-density lipoprotein; Mt5178C, mitochond
odds ratio.frequency of alcohol consumption and the risk of high
levels of serum non-HDL cholesterol remained signifi-
cant. The crude OR for high levels of serum non-HDL
cholesterol was significantly lower in daily drinkers than
in non- or ex-drinkers (OR = 0.388, 95% CI = 0.188 to
0.798, P = 0.010). After adjustment for age and BMI, or
for age, BMI, cigarette smoking, coffee consumption and
use of antihypertensive medication, a significant OR
remained. After adjustment for age and BMI only, the
OR for high levels of serum non-HDL cholesterol was
significantly lower in occasional drinkers than in non- or
ex-drinkers (OR = 0.430, 95% CI = 0.194 to 0.953, P =
0.038). However, in the case of high levels of serum non-
HDL cholesterol defined as serum non-HDL cholesterol
levels ≥190 mg/dl, the association between Mt5178C
genotype and the risk of high levels of serum non-HDL
cholesterol was not dependent on alcohol consumption.vels of serum non-HDL cholesterol by Mt5178 C/A geno-




1 (reference) 1 (reference) 1 (reference)
0.527 (0.251-1.108) 0.430 (0.194-0.953)* 0.439 (0.190-1.016)
0.388 (0.188-0.798)* 0.308 (0.142-0.665)** 0.312 (0.139-0.698)**
P for trend = 0.012 P for trend = 0.005 P for trend = 0.005
1 (reference) 1 (reference) 1 (reference)
2.461 (0.734-8.244) 2.491 (0.720-8.619) 2.499 (0.649-9.618)
2.302 (0.701-7.561) 2.022 (0.595-6.875) 2.114 (0.583-7.665)
P for trend = 0.310 P for trend = 0.385 P for trend = 0.348
1 (reference) 1 (reference) 1 (reference)
0.608 (0.221-1.672) 0.627 (0.221-1.780) 0.858 (0.279-2.640)
0.495 (0.184-1.328) 0.408 (0.146-1.139) 0.330 (0.108-1.003)
P for trend = 0.181 P for trend = 0.140 P for trend = 0.123
1 (reference) 1 (reference) 1 (reference)
1.056 (0.196-5.684) 1.014 (0.176-5.853) 0.938 (0.154-5.714)
1.484 (0.299-7.368) 1.190 (0.230-6.156) 1.325 (0.219-7.996)
P for trend = 0.513 P for trend = 0.605 P for trend = 0.560
arette smoking, coffee consumption and antihypertensive medication. *P < 0.05,
rial DNA 5178 cytosine; Mt5178A, mitochondrial DNA 5178 adenosine; OR,
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of serum non-HDL cholesterol, the association be-
tween Mt5178A genotype and the risk of high levels of
serum non-HDL cholesterol was dependent on alcohol
consumption.
Discussion
In the present study, we observed that Mt5178 C/A
polymorphism may influence the effects of habitual
smoking or habitual drinking on serum non-HDL chol-
esterol levels and the risk of high levels of non-HDL
cholesterol in middle-aged male Japanese subjects.
Cigarette smoking may increase serum non-HDL choles-
terol levels and the risk of high levels of non-HDL chol-
esterol for Mt5178A genotypic men. However, the
effects of cigarette smoking seem to be equivocal on
both of these in Mt5178C genotypic men, while alcohol
consumption may decrease both serum non-HDL chol-
esterol levels and the risk of high levels of non-HDL
cholesterol in Mt5178C genotypic men. These findings
are consistent with our previous investigations reporting
the joint effects of Mt5178 C/A polymorphism and ha-
bitual drinking or habitual smoking on the risk of dyslip-
idemia [17,18].
Wakabayashi and Groschner reported that even light
alcohol consumption is sufficient to lower serum non-
HDL cholesterol levels and that this effect of drinking
on serum non-HDL cholesterol is altered by sex [4].
Moreover, they reported that smoking is associated with
high non-HDL cholesterol in non-drinkers, that alcohol
consumption is associated with low non-HDL choles-
terol in non-smokers, and that these associations are
modified by age [3]. Here, we showed that a genetic fac-
tor also influences the effects of smoking or drinking on
serum non-HDL cholesterol levels.
Genotyping of Mt5178 C/A appears to establish per-
sonalized prevention of dyslipidemia. Abstaining from
coffee intake may be recommended for Mt5178A geno-
typic men to maximize the genetic advantage toward
lower risk of hyper-LDL cholesterolemia [22]. Smoking
cessation may be also advocated to lower the risk of
hyper-LDL cholesterolemia [18], that of hypertriglyc-
eridemia [18] and that of high levels of serum non-HDL
cholesterol. Daily alcohol consumption may reduce the
risk of hyper-LDL cholesterolemia [17] and the risk of
high levels of serum non-HDL cholesterol for men with
Mt5178C. Smoking cessation may be also urged for such
individuals to lower the risk of hypo-HDL cholesterole-
mia [18].
The mechanisms underlying the combined effects of
Mt5178 C/A polymorphism and lifestyle, namely habit-
ual smoking or habitual drinking, on serum non-HDL
cholesterol levels have not been clarified. Clinical epi-
demiological studies have indicated that individuals withthe Mt5178A genotype are more resistant to atheroscler-
otic diseases than those with the Mt5178C genotype
[13-15]. The biochemical attributes of ND2-237Met are
thought to be responsible for these antiatherogenic ben-
efits. NADH dehydrogenase is considered to be the
major physiologically and pathologically relevant reactive
oxygen species (ROS)-generating site in mitochondria,
and NADH dehydrogenase itself is sensitive to inhibition
by ROS [23]. Mitochondrial DNA is also exposed to
damage by ROS [23]. Increased mitochondrial ROS pro-
duction, mitochondrial dysfunction and mitochondrial
DNA mutation are related to atherosclerotic diseases
[23]. Considering that methionine residues act as en-
dogenous antioxidants [24], ND2-237Met may protect
NADH dehydrogenase itself and mitochondrial DNA
from ROS. Moreover, extrapolation of results using ex-
perimental mice [25] to humans assumes that ND2-
237Met also suppresses ROS production. Cigarette
smoke contains high concentrations of ROS, and is
thought to activate endogenous sources of ROS [26].
Ethanol metabolism is directly involved in the produc-
tion of ROS [27]. There may be biochemical differences
in the protection against cigarette smoking- or alcohol
consumption-induced ROS or the reduction of cigarette
smoking- or alcohol consumption-induced ROS gener-
ation between ND2-237Leu and ND2-237Met. These de-
duced differences are conjectured to bring about joint
effects of Mt5178 C/A polymorphism and cigarette
smoking or alcohol consumption on serum non-HDL
cholesterol levels or the risk of high levels of serum
non-HDL cholesterol. However, in order to determine
the mechanisms responsible for the combined effects of
ND2-237 Leu/Met genotypes and lifestyles on serum
non-HDL cholesterol levels or the risk of high levels of
serum non-HDL cholesterol, further biochemical investi-
gations are required.
Several genetic polymorphisms are reportedly associated
with the concentrations of serum non-HDL cholesterol
[5-7,28-30]. Apolipoprotein E polymorphism influences
serum non-HDL cholesterol levels [28,29]. Although in
postmenopausal women, human SA gene polymorphisms
modulate serum non-HDL cholesterol levels [30]. Fatty
acid desaturase 1 polymorphism interacts with dietary
ω-3 polyunsaturated fatty acid intake [6] or dietary
α-linolenic acid [7] to affect serum non-HDL cholesterol
levels, and COX-2 8473 thymine/cytosine polymorphism
modulates the effects of alcohol consumption on serum
non-HDL cholesterol levels [5]. Therefore, whether there
are gene-gene interactions or gene-gene-environment in-
teractions on serum non-HDL cholesterol levels warrants
further investigation.
Several potential limitations should be considered.
First, sample size was too small to validate the gene-
environment interaction. Second, we cannot rule out
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those visiting the hospital for regular medical check-ups.
Third, a cross-sectional study cannot establish a valid
causality. Fourth, we cannot rule out the possibility of
false-positive joint effects of Mt5178 C/A polymorphism
and habitual smoking or habitual drinking on serum
non-HDL cholesterol levels. Namely, Mt5178 C/A poly-
morphism may only reflect the population structure, and
another genetic factor inherited with Mt5178 C/A genotype
may interact with cigarette smoking or alcohol consump-
tion on serum non-HDL cholesterol levels. Therefore,
in order to overcome these limitations, a large-scale
population-based follow-up genome-wide association
study is necessary. Fifth, this study was an evaluation
of habitual drinking based on the frequency of alcohol
consumption. Although we have used this evaluation
in previous studies [16,17,31,32], validation of a com-
bined effect between Mt5178 C/A polymorphism and
volume of alcohol intake on serum non-HDL choles-
terol levels will be necessary. Finally, to determine the
joint effects of genetic polymorphisms and nutrient
factors on serum non-HDL cholesterol levels [6,7], a
dietary survey will also be required.
Conclusions
Mt5178 C/A polymorphism may modify the effects of
habitual smoking or habitual drinking on serum non-
HDL cholesterol levels and the risk of high levels of
non-HDL cholesterol. Our findings suggest novel gene-
environment interactions on serum non-HDL choles-
terol levels, which are considered to be a risk marker for
coronary heart disease [1,2], and may contribute to the
establishment of individualized prevention of high levels
of serum non-HDL cholesterol and, thereby, protection
against cardiovascular diseases. Moreover, considering
the advantages of studying gene-environment interac-
tions across heterogeneous groups with diverse lifestyles
[33], this investigation may provide insights in anthropo-
logical fields.
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